Uncategorized
Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too.
Bill Harris, a veteran Los Angeles photojournalist, didn’t think much of it when one morning in 2012 he woke up and found a tiny blood spot on the T-shirt he’d slept in. The next morning, he found blood in the same place on his chest — and went straight to his computer.
“Online, I could find only three things that would cause a man’s nipple to discharge blood: being an avid runner, which I wasn’t; having a subtropical fungus, which I didn’t; and breast cancer,” he said. “That was a pretty big shock.”
Harris, then just a few weeks shy of his 61st birthday, immediately called his doctor, who ordered a mammogram and ultrasound. They confirmed a cancerous growth in his right breast. Ten days later, a biopsy came back positive. The next month Harris got a right mastectomy, followed by the removal of his left breast half a year later.
“I walked into a woman’s imaging center and had to get into a pink paper robe,” he recalled. “All the women in the waiting room were staring at me.”
Like many other Ashkenazi men, Harris never had considered that he might have been born with a harmful mutation of the BRCA gene, which elevates the risk not only of breast cancer, but also of melanoma and prostate, ovarian and pancreatic cancer.
“Hundreds of other mutations in the BRCA gene are just as dangerous, but they’re not specific to Ashkenazim,” said Dr. Robert Sidlow, director of the Male BRCA Genetic Risk Program at New York’s Memorial Sloan Kettering Cancer Center. About 1 in 40 Ashkenazi Jews (those of Eastern European descent) carries the harmful mutation, compared to about 1 in 400 in the general population.
“The vast majority of patients I see are relatives of women who have breast or ovarian cancer and then get tested,” he said. Of BRCA mutation carriers, Sidlow added, “Most men are pretty happy to enroll in some kind of surveillance program once they get over the initial shock.”
Sidlow is on the Men’s Leadership Council at Sharsheret, the national Jewish nonprofit organization that educates the community about cancer risks and supports those with breast cancer and ovarian cancer.
Elana Silber, CEO of Sharsheret (Hebrew for “chain”), says it’s crucial that men with a family history of cancer undergo genetic counseling screening for BRCA and other hereditary cancer mutations.
Genetic testing is possible via a standard blood or saliva sample.
While Sharsheret is primarily considered a women’s organization, it has been using November — nicknamed Movember for its focus on men’s health — for an awareness campaign focused on Jewish men’s cancer risks.
“This is not only a women’s issue,” Silber said. “Family history is so important. When a man shares his family history with his doctor, he may not realize that he should mention that his mother had breast cancer or that his sister had ovarian cancer, as these are not generally ‘men’s diseases.’ They are not aware that these cancers could mean that they themselves are at increased risk for cancer and that they can pass on these mutations to the next generation – their daughters and their sons.”
If someone discovers he (or she) is a carrier of one of the genetic mutations with elevated cancer risks — not just BRCA but also such mutations as ATM, TP53, CHEK2, and PALB2 — there are various precautions they can take for themselves and their children. They can monitor their own health more closely, they can get encourage their children to test to see if they are carriers and, for any future children, take steps to prevent the mutated genes from being passed down.
For example, couples can conceive via in vitro fertilization, or IVF, and then test the embryos before implantation to ensure that only those unaffected by the genetic mutation are implanted.
While most women are aware of the risks of breast cancer, men generally are not — even though the disease strikes 2,500 men in the U.S. every year and kills about 500 of them, according to Sidlow. About 1-2% of men with the BRCA1 mutation and 6-7% of men with the BRCA2 mutation will develop cancer by age 80.
“This is why we recommend periodic mammograms starting at about age 50 for men who carry a BRCA2 mutation,” Sidlow said. “We like to educate these men on how to check their chests once a month and have a clinician do a breast checkup on them once a year.”
Since the BRCA1 and BRCA2 mutations also make prostate cancer more likely, men with either mutation should get PSA (prostate-specific antigen) levels in their blood tested annually beginning at age 40, rather than 50, the age at which screening generally begins, Sidlow said.
Sharsheret has been promoting the importance of learning one’s family history, genetic counseling and screening among both men and women. The 20-year-old organization also runs various peer support networks, offers financial assistance to cancer patients, provides mental health counseling and guidance to patients, caregivers, and their friends, and seeks to educate the broader Jewish community about cancer risks and support.
Peggy Cottrell, a certified genetic counselor at Sharsheret, said men in general are more reluctant to get regular checkups than women.
Ashkenazi Jewish men are at elevated risk not just of breast and prostate cancer but also of pancreatic cancer. Pancreatic cancer is particularly difficult because it’s tough to detect early enough and hard to treat. The five-year survival rate is only 11%. About 2% of BRCA1 carriers and 4% of BRCA2 carriers will develop pancreatic cancer, Sidlow estimated.
“Usually by the time pancreas cancer is clinically detected it has already spread microscopically to the liver,” Sidlow said. “But pancreas cancer is potentially curable if caught when the tumor is extremely small.”
Even among those with elevated risks, certain behaviors can improve one’s odds, such as avoiding obesity, smoking and excessive alcohol consumption.
Harris, the California photojournalist, is still fighting at age 71. While he overcame breast cancer 10 years ago, last year he was diagnosed with ampullary cancer, a rare disease related to his BRCA2 status that was discovered thanks to his participation in a UCLA study. Surgeons have removed his gall bladder, half his pancreas and part of his small intestine, and he has had to endure eight rounds of chemotherapy.
“I’m still working through the aftereffects of the chemo. I have to eat smaller quantities than before and take enzymes to supplement my digestive processes,” Harris said.
Meanwhile, his 37-year-old son discovered that he, too, carries the BRCA2 mutation, and he had a double prophylactic mastectomy and reconstruction at age 30 — just to be on the safe side.
“If there’s any history of breast, ovarian or prostate cancer in your family, get tested genetically so that you’re informed,” Harris advised. “Diagnoses happen way too late for men, and the danger is too big.”
—
The post Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too. appeared first on Jewish Telegraphic Agency.
Uncategorized
Mamdani touts ‘Babies not Bombs’ messaging after flexing political muscle in the New York primaries
(New York Jewish Week) — New York City Mayor Zohran Mamdani celebrated the victories of the progressive candidates he endorsed in New York’s Democratic primaries describing their success as a “shift in the balance of power.”
Speaking to reporters on Wednesday, the morning after the primaries, Mamdani touted the triumphs as a shift in the balance of power between “working people” and “special interests.”
Mamdani-endorsed candidates Brad Lander, Darializa Avila Chevalier and Claire Valdez won Democratic nominations for Congress. During the press conference, the mayor repeatedly highlighted their calls to restrict U.S. military aid to Israel and redirect federal funding to domestic priorities.
Following Mamdani’s election night sweep in New York, President Donald Trump posted on Truth Social that “America the Beautiful will NEVER be a Communist Country!!!”
The victories offered an early demonstration of Mamdani’s political influence beyond City Hall, as several Democratic Socialist candidates he backed, including Chevalier, defeated established Democratic incumbents in their districts.
“The working person is struggling in our city to afford basic needs,” Mamdani said, adding that Avila Chevalier’s oft-repeated slogan of investing in “Babies not Bombs,” is “the kind of conscience, the kind of clarity, the kind of conviction that has been missing in our politics for far too long.”
Mamdani responded to the president’s post on Wednesday, telling a reporter who asked whether his goal is to make America a “socialist” country that his “goal is to make America a place that every American can afford.”
When asked about federal policies that could be affected by Mamdani’s endorsed candidates, the mayor cited Valdez’s support for “foreign policy that understands human rights for all” and Lander’s commitment to co-sponsoring the Block the Bombs Act, which prohibits the sale of certain U.S.-made offensive weapons to Israel.
Mamdani also dismissed a question about whether he was concerned about how the victories would play out in November as Democrats try to win back the House.
“Every time the fight for working people takes a step forward, you will hear Republicans say that this is actually going to jeopardize the existence of that very fight,” he said.
When asked whether the election of Chevalier, who has faced scrutiny for past social media posts attacking Democrats and her appearance at an Oct. 8, 2023, pro-Palestinian rally in Times Square, could “complicate campaigns for Democrats as a whole,” Mamdani replied “No.”
“[Chevalier] often speaks about a politics of life. She speaks about ‘Babies not bombs,’” Mamdani continued. “What could be a better example of what the people of the district want to see versus what the people of the district have been forced to experience, which is tens of billions of dollars being spent at a national level to bomb children overseas, while children in our own districts are struggling.”
The post Mamdani touts ‘Babies not Bombs’ messaging after flexing political muscle in the New York primaries appeared first on The Forward.
Uncategorized
Jewish anti-Zionist David Orkin defeats incumbent in NY Assembly primary
(New York Jewish Week) — David Orkin, a Jewish anti-Zionist attorney and democratic socialist, defeated incumbent New York State Assemblymember Jenifer Rajkumar in Tuesday’s Democratic primary. Orkin won State Assembly District 38, which includes parts of Queens.
Orkin, an immigrant workers’ rights attorney and union organizer, received 58.8% of the vote, while Rajkumar, who has represented the district since 2021 and is the first South Asian woman ever elected to office in the state, received 40.9%. The district covers a swath of Queens, including parts of Ridgewood, Glendale, Ozone Park, Woodhaven and Richmond Hill.
“Pro-Palestine candidates are sweeping in NYC tonight,” Jewish Voice for Peace Action wrote in a post on Instagram celebrating Orkin’s win Tuesday. “Palestine was on the ballot — and won. David will be a champion for Palestinian freedom in Albany.”
The post from JVP Action echoed a message Orkin had highlighted throughout his campaign.
“It’s so incredibly meaningful to me to be running this race as an anti-Zionist Jew, to be one of the few anti-Zionist Jewish voices that is in an elected seat in the state government,” Orkin said in an Instagram reel posted by Jewish Voice for Peace Action earlier this month.
He added that, if elected, he would be able to go in front of the state legislature and assert that “criticizing Israel for genocide, demanding an end to the occupation, demanding an end to funding war abroad is not antisemitic.”
Orkin’s victory came amid a strong night for democratic socialist candidates across New York City, including left-wing congressional candidates Brad Lander, Darializa Avila Chevalier and Claire Valdez, who also defeated establishment-backed opponents in their primaries.
While Orkin was not endorsed by New York City Mayor Zohran Mamdani, whose winning endorsements of Lander, Chevalier and Valdez signaled a pro-Palestinian lurch for the party in the city with the world’s largest Jewish population outside of Israel. Nonetheless, his victory elevated a self-described anti-Zionist to the ranks of New York’s elected officials at a time when debates over Israel have become increasingly prominent within Democratic politics.
While Israel-related issues were not listed on Orkin’s platform, which centered on affordability and immigration, he repeatedly expressed his support for a “free Palestine” and attacked Rajkumar’s record of support for the Jewish state during his campaign.
“In the past several years my opponent AM Rajkumar has walked in the Israel day parade but has said NOTHING against the war in Gaza, occupation of Palestine, or Islamophobic attacks faced by the people of New York,” Orkin wrote in a May post on X.
Rajkumar, who was a close political ally of former New York City Mayor Eric Adams, in her campaign platform vowed to combat antisemitism.
After establishing a Jewish Voice for Peace chapter in Tucson, Arizona, in 2014, Orkin remained involved in pro-Palestinian activism as a member of the anti-Zionist activist group.
“I’ve been involved in the Jewish Palestine Solidarity Movement for 12, 13 years,” Orkin told Democratic Left last month. “I’ve dedicated part [of my] life to making sure that Jewish people are creating religious spaces outside of Zionism, and to making more space for Palestinian organizing to have an impact.”
On the campaign trail, Orkin received a host of endorsements from prominent progressive groups and lawmakers, including Vermont independent Sen. Bernie Sanders, Democratic New York Rep. Alexandria Ocasio-Cortez, Jews for Racial and Economic Justice, JVP Action and NYC Democratic Socialists for America.
Rajkumar was endorsed by ActJew, the new nonprofit focused on combatting antisemitism, as well as the Queens Jewish Alliance and Assemblymembers Sam Berger, Kalman Yeger and Chuck Lavine.
Orkin received over $290,000 in campaign contributions for the election cycle, including over $156,000 from the office of the state comptroller, while Rajkumar received over $270,000, including $9,000 from health care executive Daniel Lowy.
“I have dedicated my life fighting for immigrants and workers, I am proud to have earned their support in this election, and I look forward to spending the rest of my life winning the beautiful and joyous lives we deserve,” Orkin said in a statement, according to QNS.
The post Jewish anti-Zionist David Orkin defeats incumbent in NY Assembly primary appeared first on The Forward.
Uncategorized
Half of Americans think the U.S. is ‘too supportive’ of Israel
(JTA) — A new survey found that 48% of American voters think the United States is “too supportive” of Israel, the highest since the pollster started asking the question in 2017.
The survey published Wednesday by Quinnipiac University also found that 60% of respondents reported that military intervention in Iran was “not worth it” as opposed to 34% of voters who said it was “worth it.”
The number of respondents who think the U.S. support of Israel is about right is 38%, while just 7% think the U.S. is not supportive enough of Israel, the poll found.
Broken down by party, 66% of Democrats think the U.S. is too supportive of Israel, while 9% think it is not supportive enough and 18% think U.S. support for Israel is about right.
Among Republicans, 20% think the U.S. is too supportive of Israel, 69% think American support for Israel is “about right,” and 6% think the U.S. is not supportive enough.
Among independent voters, 55% think the U.S. is too supportive of Israel, 34% think U.S. support for Israel is about right, and 7% think the U.S. is not supportive enough.
The poll data were released one day after three Democrats critical of Israel swept their House primary races in New York City, and in races around the country even some reliably pro-Israel Democratic candidates distanced themselves from the pro-Israel lobby AIPAC.
A survey last year by Gallup found dwindling support for Israel among Democrats, as well as waning support among Republicans.
Still the party divide was also in sharp evidence in the latest poll. In responses to the question about whether the Iran war was “worth it”, Democrats disfavored military action in Iran at 93% and independents at 66%, while 75% of Republicans surveyed thought it was “worth it.”
Given a list of 10 issues and asked which, if any, they considered priorities in their decision-making process in the election for the U.S. House of Representatives, 41% of voters cited the Israeli-Palestinian conflict, above AI data centers (38%) and Donald Trump (38%). The high cost of living (70%) and health care (59%) topped the list.
The Quinnipiac poll was conducted from June 18 to 22, and includes responses from 1,165 self-identified registered voters.
The margin of error is 3.4 percentage points.
Among those surveyed, 48% said they had an unfavorable view of Israeli Prime Minister Benjamin Netanyahu. Twenty percent said they had a favorable opinion, and 30% “haven’t heard enough” about him.
“Netanyahu gets poor marks from American voters as their appetite for supporting Israel wanes, with the share of voters who think the U.S. is too supportive of Israel hitting a new high,” Quinnipiac polling analyst Tim Malloy wrote in the report.
Voters were also asked about their views on the June 17 memorandum of understanding with Iran, which begins a 60-day negotiation period that does not outline an end to Iran’s nuclear program.
“After months of diplomatic fits and starts, global economic repercussions and a broad loss of life in the region, a majority of voters make their feelings clear: the Iran war was a bad idea,” Malloy wrote.
Voters who are either not confident or “not so confident” that the deal will succeed numbered 59%, and 61% think it is either likely or very likely that Iran will develop nuclear weapons.
The post Half of Americans think the U.S. is ‘too supportive’ of Israel appeared first on The Forward.
